CS logo
small CS logo
Philippine General Hospital - University of the Philippines Manila

Manila, Metro Manila, Philippines
Hospital in Manila
HXHP+36Q, Taft Ave, Ermita, Manila, 1000 Metro Manila

About Philippine General Hospital - University of the Philippines Manila


The Philippine General Hospital, simply referred to as UP–PGH or PGH, is a tertiary state-owned hospital administered and operated by the University of the Philippines Manila. It is designated as the National University Hospital, and the national government referral center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Philippine General Hospital - University of the Philippines Manila


During the past decade, Philippine General Hospital - University of the Philippines Manila conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Philippine General Hospital - University of the Philippines Manila" #1 collaborator was "Calmoseptine, Inc." with 2 trials as a collaborator, "East Avenue Medical Center, Philippines" with 2 trials as a collaborator, "Jose R. Reyes Memorial Medical Center" with 2 trials as a collaborator, "Makati Medical Center" with 2 trials as a collaborator and "Quirino Memorial Medical Center, Philippines" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 41 trials.

Clinical Trials Conditions at Philippine General Hospital - University of the Philippines Manila


According to Clinical.Site data, the most researched conditions in "Philippine General Hospital - University of the Philippines Manila" are "Burn" (1 trials), "COVID-19" (1 trials), "COVID-19 Pandemic" (1 trials), "Cerebral Venous Thrombosis" (1 trials) and "Cognitive Impairment" (1 trials). Many other conditions were trialed in "Philippine General Hospital - University of the Philippines Manila" in a lesser frequency.

Clinical Trials Intervention Types at Philippine General Hospital - University of the Philippines Manila


Most popular intervention types in "Philippine General Hospital - University of the Philippines Manila" are "Drug" (5 trials), "Other" (2 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Banana Leaf Dressing" (1 trials), "Best Available Therapy (BAT)" (1 trials), "Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)" (1 trials), "Calmoseptine Ointment" (1 trials) and "Cefazolin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Philippine General Hospital - University of the Philippines Manila


The vast majority of trials in "Philippine General Hospital - University of the Philippines Manila" are 10 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Philippine General Hospital - University of the Philippines Manila


Currently, there are NaN active trials in "Philippine General Hospital - University of the Philippines Manila". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Philippine General Hospital - University of the Philippines Manila, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Philippine General Hospital - University of the Philippines Manila, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".